BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/9/2026 11:25:17 AM | Browse: 7 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Application of spatial omics, multi-omics, and artificial intelligence in inflammatory bowel disease: Current applications and emerging opportunities
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Charles Adolfu Shirima, Gibson Albert Sabuholo, Lucia Bubulac, Priya Patel and Gratiela Gradisteanu Pircalabioru |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gratiela Gradisteanu Pircalabioru, Academic Fellow, Associate Professor, Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, sos Panduri 90, Bucharest 030014, Romania. gratiela.gradisteanu@icub.unibuc.ro |
| Key Words |
Inflammatory bowel disease; Multi-omics; Crohn’s disease; Artificial intelligence; Spatial-omics; Ulcerative colitis; Microbiota |
| Core Tip |
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, arises from complex, spatially organized interactions between host genetics, immune responses, epithelial integrity, and the intestinal microbiota. Emerging multi-omics and spatial-omics technologies now enable high-resolution, tissue-context-preserved profiling of these processes, revealing disease-defining cellular niches and host-microbiome interactions. Artificial intelligence (AI) provides a critical framework for integrating high-dimensional datasets, uncovering non-linear relationships, and translating molecular complexity into clinically actionable insights. The convergence of multi-omics, spatial-omics, and AI holds strong promise for precision medicine in IBD, enabling improved disease stratification, identification of spatial biomarkers for progression and cancer risk, and the development of next-generation, non-animal disease models. |
| Citation |
Shirima CA, Sabuholo GA, Bubulac L, Patel P, Gradisteanu Pircalabioru G. Application of spatial omics, multi-omics, and artificial intelligence in inflammatory bowel disease: Current applications and emerging opportunities. World J Gastroenterol 2026; In press |
 |
Received |
|
2026-01-26 03:02 |
 |
Peer-Review Started |
|
2026-01-26 03:13 |
 |
First Decision by Editorial Office Director |
|
2026-02-09 09:50 |
 |
Return for Revision |
|
2026-02-09 09:50 |
 |
Revised |
|
2026-02-20 21:51 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-05-09 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-05-09 11:25 |
 |
Articles in Press |
|
2026-05-09 11:25 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.